Aldosterone, salt and cardiac fibrosis

Clinical and Experimental Hypertension

Volumn 19, Issue 5-6, 1997, Pages 885-899

  Funder, John W ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

11 hydroxysteroid dehydrogenase; Hypertension; Mineralocorticoid Receptors

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; ALDOSTERONE; MINERALOCORTICOID RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; BLOOD PRESSURE REGULATION; CONFERENCE PAPER; HEART HYPERTROPHY; HEART MUSCLE FIBROSIS; HORMONE ACTION; HORMONE RECEPTOR INTERACTION; HYPERTENSION; NEWBORN; NONHUMAN; PATHOPHYSIOLOGY; RAT; RECEPTOR DENSITY; RECEPTOR OCCUPANCY; SODIUM RETENTION;

EID: 0030814350     PISSN: 10641963     EISSN: None     Source Type: Journal    
DOI: 10.3109/10641969709083193     Document Type: Conference Paper

References (25)

1. Wehling M, Neylon C.B., Fullerton, M., Bobik, A., Funder, J.W. Nongenomic effects of aldosterone on intracellular calcium in vascular smooth muscle cells. Circ. Res. 1995; 76: 973-979.
2. Krozowski Z.S., Funder, J.W. Renal mineralocorticoid receptors and hippocampal corticosterone binding species have identical intrinsic steroid specificity. Proc Natl Acad Sci USA 1983; 80: 6056-6060.
3. Affiza, J.L., Weinberger, C., Glaser, T.M., Handelin, B.L., Housman, D.E., Evans, R.M. Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptors. Science 1987; 237: 268-275.
4. Mangelsdorf, D.J., Thummel, C., Beato, M., Herrlich, P., Schutz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P., Evans, R.M. The nuclear receptor superfamily: the second decade. Cell 1995; 83: 835-839.
5. Myles, K., Funder, J.W. Type I (mineralocorticoid) receptors in the guinea pig. Am J Physiol 1994; 267: E268-E272.
6. Naray-Fejes-Toth, A., Fejes-Toth, G. Glucocorticoid receptors mediate mineralocorticoid-like effects in cultured collecting duct cells. Am J Physiol. 1990; 259: F672-F678.
7. Funder, J.W., Pearce, P., Myles, K., Roy, L.P. Apparent mineralocorticoid excess, pseudohypoaldosteronism and urinary electrolyte excretion: towards a redefinition of "mineralocorticoid" action. FASEB J 1990; 4: 3234-3238.
8. Krozowski, Z.S., Stewart, P., Obeyesekere, V., Li, K., Feffari, P. Mutations in the 11β hydroxysteroid dehydrogenase Type 2 enzyme associated with hypertension and possibly stillbirth. Clin Exp Hypertens.(this issue).
9. Wilson, R.C., Krozowski, Z.S., Li, K., Obeyesekere, V., Razzaghy-Azar, M.M., Harbison, D., Wei, J.Q., Shackleton, C.H.L., Funder, J.W., New, M.I. A mutation in the HSD11B2 gene in a family with Apparent Mineralocorticoid Excess. J Clin Endocrinol Metab 1995; 80: 2263-2266.
10. Mune, T., Rogerson, F.M., Nikkila, H., Agarwal, A.K., White, P.C. Human hypertension caused by mutations in the gene encoding the kidney isozyme of 110-hydroxysteroid dehydrogenase. Nat Genet 1995; 10: 394-399.
11. Wilson, R.C., Harbison, M.D., Krozowski, Z.S., Funder, J.W., Shackleton, C.H.L., Hanauske-Abel, H.M., Wei, J-Q., Hertecant, J., Moran, A., Neiberger, R.E., Balfe, J.W., Fattach, A., Daneman, D., Licholai, T., New, M.I. Several homozygous mutations in the gene for 11β-hydroxysteroid dehydrogenase Type 2 in patients with Apparent Mineralocorticoid Excess. J Clin Endocrinol Metab 1995; 80: 3145-3150.
12. Albiston, A., Obeyesekere, V., Smith, R., Krozowski, Z.S. Cloning and tissue distribution of the human 11-β hydroxysteroid dehydrogenase type II enzyme. Mol Cell Endocrinol 1994; 105: R11-R17.
13. Funder, J.W. Enzymes and receptors: challenges and future directions. Steroids 1994; 59: 164-169.
14. Funder, J.W., Myles, K. Exclusion of cortic oster one from epithelial mineralocorticoid receptors is insufficient for selectivity of aldosterone action: in vivo binding studies. Endocrinology 1996, in press.
15. Gomez-Sanchez, E.P., Venkataraman, M.T., Thwaites, D., Fort, C. ICV infusion of corticosterone antagonizes ICV-aldosterone hypertension. Am J Physiol 1990; 258: E649-E653.
16. Gomez-Sanchez, E.P., Fort, C., Thwaites, D. Central mineralocorticoid receptor antagonism blocks hypertension in Dahl S/JR rats. Am J Physiol 1992; 262: E96-E99.
17. Gomez-Sanchez, E.P., Fort, C.M., Gomez-Sanchez, C.E. Intracerebroventricular infusion of RU28318 blocks aldosterone-salt hypertension. Am J Physiol 1990; 258: E482-E484.
18. Brilla, C.G., Weber, K.T. Mineralocorticoid excess, dietary sodium and myocardial fibrosis. J Lab Clin Med 1992; 120: 893-901.
19. Young, M.J., Funder, J.W. The renin-angiotensin-aldosterone system in experimental mineralocorticoid-salt induced cardiac fibrosis. Am J Physiol 1996, in press.
20. Young, M., Head, G., Funder, J.W. Determinants of cardiac fibrosis in experimental hypermineralocorticoid states. Am J Physiol 1995; 269: E657-E662.
21. Young M., Fullerton, M., Dilley, R., Funder, J.W. Mineralocorticoids, hypertension and cardiac fibrosis. J Clin Invest 1994; 93: 2578-2583.
22. Guarda, E., Myers, P., Brilla, C., Tyagi, S., Weber, K.T. Endothelial cell induced modulation of cardiac fibroblast collagen metabolism. Cardiovasc Res. 1993; 27: 1004-1008.
23. Fullerton, M.J., Funder, J.W. Aldosterone and cardiac fibrosis: in vitro studies. Cardiovasc Res. 1994; 28: 1863-1867.
24. Sato, A., Funder, J.W. High glucose stimulates aldosterone-induced hypertrophy via Type I mineralocorticoid receptors in neonatal rat cardiomyocytes. Endocrinology 1996, in press.
25. Kageyama, Y., Suzuki, H., Saruta, T. Role of glucocorticoid in the development of glycyrrhizin-induced hypertension. Clin Exp Hyperten. 1994; 16: 761-778.